奎斯特诊断公司简介

奎斯特诊断公司（Quest Diagnostics）是美国最大的临床诊断公司，也是是著名的生化医疗器材测试商。这家公司发起于1967年，期间经历多次并购，1996年在美国纽交所上市。Quest在美国拥有31个区域性大型诊断中心，155家快速反应实验室，超过2100个病人服务中心，每年诊断超过1亿个标本。

奎斯特诊断公司为健康护理专业人员提供专业知识，协助他们做出正确诊断，来改善病患的健康状况。这家公司透过所属的实验室和病患服务中心，为美国地区的民众提供诊断测试服务，并透过其人数众多的医疗和科学员工提供详尽的咨询服务。

目前，美国前三名公司的市场占有率超过60％，市场集中度很高。在欧美和日本等发达国家，独立实验室已经占据临床检验市场的1/3。而中国99％的检验业务仍在医院检验科完成。但相比Quest拥有的3000多项检验项目，中国的大型医院也只有500—1000个项目。2006年收入63亿美元。

Quest Diagnostics Incorporated (NYSE: DGX) is a United States corporation which provides clinical laboratory services. The company has operations in the United States, United Kingdom, Mexico and through its wholly-owned subsidiary Quest Diagnostics India Pvt. Ltd, a laboratory in India in addition to service locations located in Brazil. Quest Diagnostics also has collaborative agreements internationally with various hospitals and clinics. Quest Diagnostics also has operations in the US Territory of Puerto Rico.

Quest Diagnostics is a member of the Fortune 500 and the S&P 500. The company’s corporate headquarters were previously located in Teterboro, New Jersey where the largest business unit is located. Currently, the corporate headquarters are located in Madison, New Jersey having moved there in October 2007 from Lyndhurst, New Jersey.

奎斯特诊断公司的历史

1967: Founded by Paul A. Brown, MD as Metropolitan Pathology Laboratory, Inc., in New York.
1969: Name Changed to MetPath, Inc., in Teaneck, New Jersey.
1982: MetPath was acquired by what was then known as Corning Glass Works, and subsequently renamed Corning Clinical Laboratories.
1997: Quest Diagnostics becomes an independent company as a spin-off from Corning.
1997: Acquires clinical laboratory division of Branford, CT-based Diagnostic Medical Laboratory, Inc. (DML).
1999: Acquires SmithKline Beecham Clinical Laboratories; GlaxoSmithKline still holds a large portion of Quest Diagnostics stock. The SmithKline Beecham acquisition includes a joint venture ownership with CompuNet Clinical Laboratory
2000: Launch of Six Sigma program leading the charge to raise the quality of healthcare delivery in the United States.
2001: Completes acquisition of Ohio-based MedPlus, Inc. (NASDAQ: MEDP), a healthcare technology company.
2002: Completes acquisition of Virginia-based American Medical Laboratories, Inc. (AML) and an affiliated company of AML, LabPortal, Inc., for approximately $500 million in cash.
2003: Completes acquisition of California-based Unilab Corporation (NASDAQ: ULAB) in a transaction valued at approximately $800 million .
2005: Completes acquisition of Kansas-based LabOne, Inc. (NASDAQ: LABS) for approximately $934 million.
2006: Completes acquisition of Virginia-based Focus Diagnostics, Inc., an infectious and immunologic disease laboratory, for approximately $185 million in cash.
2007: Quest Diagnostics celebrates its 10th year after being spun off from Corning.
2007: Completes acquisition of Sweden-based Hemocue, a point-of-care diagnostic testing company.
2007: Acquires AmeriPath, becoming the leading provider of cancer diagnostic testing services.
2010: Laid off 70 percent of processor’s in Lenexa and have cut costs and employee overtime due to decline of clients, poor sales and poor managment.